Loading company…
ID 405328863 · FY 2019–2024 · 6 years
კომპანიის ძირითადი საქმიანობაა საბიუმო ვაჭრობა ფარმაცევტული საქონლით, კომპანიას მინიჭებული აქვს სპეციალური სავაჭრო კომპანიის სტატუსი.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|
| Total Revenue | 18,187 | 14,053 | 8,010 | 8,444 | 5,326 | 16,323 | -2.1% |
| Total COGS | -13,613 | -10,630 | -6,513 | -7,641 | -4,273 | -12,884 | -1.1% |
| Gross Profit | 4,575 | 3,423 | 1,497 | 803 | 1,053 | 3,438 | -5.6% |
| Gross Margin | 25.2% | 24.4% | 18.7% | 9.5% | 19.8% | 21.1% | |
| Total Operating Expenses | 3,654 | 2,472 | 2,021 | 2,705 | 1,177 | 2,116 | -10.3% |
| EBITDA | 8,228 | 5,894 | 3,519 | 3,508 | 2,230 | 5,555 | -7.6% |
| EBITDA Margin | 45.2% | 41.9% | 43.9% | 41.5% | 41.9% | 34.0% | |
| Total D&A | -8 | -51 | -52 | -45 | -25 | -20 | +18.8% |
| EBIT / Operating Income | 8,220 | 5,843 | 3,467 | 3,463 | 2,205 | 5,535 | -7.6% |
| Total Other Income | 223 | 3,280 | 2,086 | 2,560 | 1,262 | 2,328 | +59.9% |
| Profit Before Tax | 8,442 | 9,124 | 5,553 | 6,023 | 3,467 | 7,863 | -1.4% |
| Total Income Tax | 0 | 0 | -0 | -0 | -0 | -4 | +106.1% |
| Net Profit / (Loss) | 8,442 | 6,493 | 3,455 | 3,199 | 2,234 | 5,461 | -8.3% |
| Net Margin | 46.4% | 46.2% | 43.1% | 37.9% | 41.9% | 33.5% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).